Sander Ruitenberg

Responsible for developing digital programs for the immunology portfolio, innovating customer engagement and service delivery models with an omnichannel focus. Created omnichannel customer engagement strategies and implementation models, and developed connected care programs with new ways to access product websites and connected solutions.

Focus on building transformative governance frameworks and excellence models that will enable us to excel in Connected Health product design and development, as part of our Data & Digital efforts within Global Drug Development. In particular, these efforts will drive the activation of customer value via well designed and configured Connected Health product systems that are highly amenable to market adoption.

Focused on building a chatbot platform in support of the Novartis chatbot portfolio, established a governance framework and development model, with an industry-leading platform approach.

Led the development, launch and roll-out of a website product based on the Drupal content management framework.

Launched Xolair® in dermatology for the chronic spontaneous urticaria indication and created the digital Novartis in dermatology presence with the “Skin to Live in” social media program.

Temporary transition support following the sale of Toctino® to GSK.

Lead the launch for Toctino® for chronic hand eczema and built a global multi-channel promotional platform.